Clinical Trial Update: Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of BI 1744 CL in chronic obstructive pulmonary disease has completed, with results posted on 2014-06-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BI 1744 CL

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-06-16